Cargando…
Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion
BACKGROUND: We evaluated malignancy according to the characteristics of pericardial fluid in symptomatic Japanese patients undergoing pericardiocentesis and computed tomography (CT). METHODS: This was a retrospective, single-center, observational study of 125 symptomatic patients undergoing pericard...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176742/ https://www.ncbi.nlm.nih.gov/pubmed/34082695 http://dx.doi.org/10.1186/s12872-021-02091-6 |
_version_ | 1783703309280870400 |
---|---|
author | Nakamura, Takashi Okune, Mana Yasuda, Masakazu Watanabe, Heitaro Ueno, Masafumi Yamaji, Kenji Mizutani, Kazuki Kurita, Takashi Nakazawa, Gaku |
author_facet | Nakamura, Takashi Okune, Mana Yasuda, Masakazu Watanabe, Heitaro Ueno, Masafumi Yamaji, Kenji Mizutani, Kazuki Kurita, Takashi Nakazawa, Gaku |
author_sort | Nakamura, Takashi |
collection | PubMed |
description | BACKGROUND: We evaluated malignancy according to the characteristics of pericardial fluid in symptomatic Japanese patients undergoing pericardiocentesis and computed tomography (CT). METHODS: This was a retrospective, single-center, observational study of 125 symptomatic patients undergoing pericardiocentesis. The patients were classified into two groups: a malignancy group and a non-malignancy group, according to the primary disease and cytology of the pericardial effusion (PE). We compared the pericardial fluid sample and CT measurements between both groups. RESULTS: All patients were diagnosed as having exudative PE by Light’s criteria. PE with malignant cells was demonstrated in 76.8% of the malignancy group patients. Pericardial to serum lactate dehydrogenase (LDH) ratio > 0.6, as one of Light’s criteria, was associated with malignancy (p = 0.017). Lower serum brain natriuretic peptide (BNP) concentration was also associated with malignancy (BNP: 126.9 ± 89.8 pg/ml vs 409.2 ± 97.7 pg/ml, malignancy vs non-malignancy groups, respectively; p = 0.037). A significant difference was observed in pericardial fluid glucose level between the malignancy and non-malignancy groups (pericardial fluid glucose: 78.24 ± 48.29 mg/dl vs 98.41 ± 44.85, respectively; p = 0.048). Moreover, CT attenuation values (Hounsfield units (HU)) tended to be higher in the malignancy group vs the non-malignancy group (22.7 [interquartile range (IQR), 17.4–26.0] vs 17.4 [IQR, 13.7–26.4], respectively; p = 0.08). The sensitivity and specificity of pericardial fluid glucose level ≤ 70 mg/dl and CT attenuation values > 20 HU were 40.9% and 89.6%, respectively, in the malignancy group. The positive- and negative predictive values of pericardial fluid glucose level ≤ 70 mg/dl and CT attenuation values > 20 HU were 85.7% and 50.0%, respectively, in the malignancy group. Pericardial fluid glucose level ≤ 70 mg/dl and CT attenuation values > 20 HU were cutoff values associated with malignancy (p = 0.012). CONCLUSIONS: Lower pericardial fluid glucose level with higher CT attenuation values may suggest malignancy-related PE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-021-02091-6. |
format | Online Article Text |
id | pubmed-8176742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81767422021-06-04 Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion Nakamura, Takashi Okune, Mana Yasuda, Masakazu Watanabe, Heitaro Ueno, Masafumi Yamaji, Kenji Mizutani, Kazuki Kurita, Takashi Nakazawa, Gaku BMC Cardiovasc Disord Research BACKGROUND: We evaluated malignancy according to the characteristics of pericardial fluid in symptomatic Japanese patients undergoing pericardiocentesis and computed tomography (CT). METHODS: This was a retrospective, single-center, observational study of 125 symptomatic patients undergoing pericardiocentesis. The patients were classified into two groups: a malignancy group and a non-malignancy group, according to the primary disease and cytology of the pericardial effusion (PE). We compared the pericardial fluid sample and CT measurements between both groups. RESULTS: All patients were diagnosed as having exudative PE by Light’s criteria. PE with malignant cells was demonstrated in 76.8% of the malignancy group patients. Pericardial to serum lactate dehydrogenase (LDH) ratio > 0.6, as one of Light’s criteria, was associated with malignancy (p = 0.017). Lower serum brain natriuretic peptide (BNP) concentration was also associated with malignancy (BNP: 126.9 ± 89.8 pg/ml vs 409.2 ± 97.7 pg/ml, malignancy vs non-malignancy groups, respectively; p = 0.037). A significant difference was observed in pericardial fluid glucose level between the malignancy and non-malignancy groups (pericardial fluid glucose: 78.24 ± 48.29 mg/dl vs 98.41 ± 44.85, respectively; p = 0.048). Moreover, CT attenuation values (Hounsfield units (HU)) tended to be higher in the malignancy group vs the non-malignancy group (22.7 [interquartile range (IQR), 17.4–26.0] vs 17.4 [IQR, 13.7–26.4], respectively; p = 0.08). The sensitivity and specificity of pericardial fluid glucose level ≤ 70 mg/dl and CT attenuation values > 20 HU were 40.9% and 89.6%, respectively, in the malignancy group. The positive- and negative predictive values of pericardial fluid glucose level ≤ 70 mg/dl and CT attenuation values > 20 HU were 85.7% and 50.0%, respectively, in the malignancy group. Pericardial fluid glucose level ≤ 70 mg/dl and CT attenuation values > 20 HU were cutoff values associated with malignancy (p = 0.012). CONCLUSIONS: Lower pericardial fluid glucose level with higher CT attenuation values may suggest malignancy-related PE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-021-02091-6. BioMed Central 2021-06-03 /pmc/articles/PMC8176742/ /pubmed/34082695 http://dx.doi.org/10.1186/s12872-021-02091-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Nakamura, Takashi Okune, Mana Yasuda, Masakazu Watanabe, Heitaro Ueno, Masafumi Yamaji, Kenji Mizutani, Kazuki Kurita, Takashi Nakazawa, Gaku Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion |
title | Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion |
title_full | Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion |
title_fullStr | Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion |
title_full_unstemmed | Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion |
title_short | Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion |
title_sort | impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176742/ https://www.ncbi.nlm.nih.gov/pubmed/34082695 http://dx.doi.org/10.1186/s12872-021-02091-6 |
work_keys_str_mv | AT nakamuratakashi impactofpericardialfluidglucoselevelandcomputedtomographyattenuationvaluesondiagnosisofmalignancyrelatedpericardialeffusion AT okunemana impactofpericardialfluidglucoselevelandcomputedtomographyattenuationvaluesondiagnosisofmalignancyrelatedpericardialeffusion AT yasudamasakazu impactofpericardialfluidglucoselevelandcomputedtomographyattenuationvaluesondiagnosisofmalignancyrelatedpericardialeffusion AT watanabeheitaro impactofpericardialfluidglucoselevelandcomputedtomographyattenuationvaluesondiagnosisofmalignancyrelatedpericardialeffusion AT uenomasafumi impactofpericardialfluidglucoselevelandcomputedtomographyattenuationvaluesondiagnosisofmalignancyrelatedpericardialeffusion AT yamajikenji impactofpericardialfluidglucoselevelandcomputedtomographyattenuationvaluesondiagnosisofmalignancyrelatedpericardialeffusion AT mizutanikazuki impactofpericardialfluidglucoselevelandcomputedtomographyattenuationvaluesondiagnosisofmalignancyrelatedpericardialeffusion AT kuritatakashi impactofpericardialfluidglucoselevelandcomputedtomographyattenuationvaluesondiagnosisofmalignancyrelatedpericardialeffusion AT nakazawagaku impactofpericardialfluidglucoselevelandcomputedtomographyattenuationvaluesondiagnosisofmalignancyrelatedpericardialeffusion |